The Latest Breaking News from Vaccine

Health Dept launches special camp in Chennai to provide Measles-Rubella vaccine to 27.42 lakh children aged 9 months-15 years in cyclone-hit districts. 10 lakh doses sought from Union govt. 6,421 camps organised, 4.69 lakh persons benefited, 6,403 with fever, 71,561 with cough/cold.

The global anti-vaccine movement and vaccine hesitancy that accelerated during the COVID-19 pandemic show no signs of abating.

Continuing to pay for COVID-19 vaccines and treatments will cost Australians hundreds of millions of dollars, with the threat posed by the virus far from over.

The Urban League and other groups worked hard during the pandemic to raise vaccination rates among Black Americans. The gap is smaller, but Blacks are still less likely than whites to receive COVID-19 and influenza vaccines.

Britain’s biggest drugmaker acquires Seattle-based firm Icosavax, expanding vaccine and immune therapy business

UK Health Security Agency (UKHSA) has issued a strong call to action, urging eligible individuals, especially those from ethnic minority groups, to book their flu and COVID-19 vaccines.

The African-led trial was initiated in December 2020 but came to an early halt last month. Its conclusive findings are to be released in 2024.

You may have read recent alarming reports of a cough that “lasts 100 days” is “quickly spreading across the UK” and can “fracture ribs”. If you didn’t look beyond the headlines, you might have missed the fact that the reports are about whooping cough.

Two new COVID-19 vaccines targeting the new Omicron variant of the virus are now available in Australian pharmacies around the nation.

Special medical camps held in cyclone-affected districts of TN screen 1.3L; MR vaccine advised for children in flood-hit areas. Health Minister launched camps in 679 places, 200 each in Tiruvallur & Chengalpattu, 100 in Kancheepuram. Screening for dengue, chikungunya, diarrhoea, sore throat & cough; MR vaccine advised for children in…

Scientists have offered a new explanation for why COVID-19 vaccines that contained adenoviruses carried a rare-but-serious risk of blood clotting.